Thought Leadership
LifeSci Talks COA Series | Nothing Remains the Same: Why Measures Have to Evolve
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with RJ Wirth, CEO and Consulting Psychometrician at Vector Psychometric Group, to talk about why the measures we rely on are living things rather than fixed artifacts....
XTalks | eCOA: Has It Lived Up to the Promise? A Realistic Assessment for Today's Trials
Despite two decades of technological advancement, the debate between paper and electronic clinical outcome assessments (eCOA) remains unresolved. This webinar revisits the assumptions that continue to shape data collection strategies and examines whether current practice reflects...
SSCPs Are Not Labeling: Compliant AI Processes for Reduced Cost & Turnaround
In this fireside chat, TransPerfect Medical Device's President Marc Miller sits down with Dr. Keith Morel, VP of Regulatory Compliance at Qserve, to unpack a critical question facing medical device manufacturers under MDR: can you reduce the translation review process for...
How to Make Your Academy Succeed at Global Scale—Lessons Learned on What Works and What Doesn’t
Most life sciences and MedTech companies launch a corporate academy with strong strategic intent, whether that’s executive sponsorship, a named platform, a dedicated budget, or a curriculum mapped to business goals. After launch, however, these same organizations all too often...
IMP Labeling Workflows That Reduce Relabeling Risk and Start-Up Delays
Investigational medicinal product (IMP) labeling sits at the heart of clinical trial supply, impacting departments across pharmaceutical organizations, from clinical operations and regulatory affairs to quality assurance and beyond. When labeling activities are managed across...
The Missing Link: Why Study Design Makes or Breaks a Clinical Trial
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Farrell Healion, Founder and Principal Consultant at OptiTrial, to explore why study design is so often the overlooked "missing link" in clinical...
Xtalks | EU Clinical Trial Regulation: Latest Developments and Upcoming Opportunities
The EU clinical trial landscape has changed significantly since Regulation (EU) No 536/2014 became applicable on January 31, 2022, and sponsors now need a clear view of how the framework is operating in practice and where it may evolve next. This webinar explores the current...
LifeSci Talks COA Series | Are We Sacrificing Good for Perfect in Clinical Outcome Assessment?
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Stacie Hudgens, Chief Scientific and Strategy Officer at Clinical Outcome Solutions, to discuss whether the field of clinical outcome assessment has started...
AI in Medical Information: Challenges, Opportunities, and the Path to Compliant Content at Scale
Medical information teams are being asked to do more with less; faster turnaround, broader content demands, and zero tolerance for inaccuracy. AI offers a way forward, but adoption comes with real challenges: how do you validate accuracy, integrate literature review, and build...
Xtalks | Improve Recruitment Outcomes Through More Diverse Clinical Trials
Since the advent of artificial intelligence (AI), medical device manufacturers have been early adopters for product enhancements. Now, manufacturers are evaluating their regulated content and other production processes for suitable applications of AI and automation technology. ...
LifeSci Talks COA Series | More Than an Aspiration: Building a Patient-Centric Evidence Strategy That Lasts
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Lina Eliasson PhD CPsycho, Founding Partner at Sprout Health Solutions, to discuss how pharma companies of all sizes can build a comprehensive, patient-centric...
LifeSci Talks COA Series | Building Fit-for-Purpose PRO Instruments: Focused Modern Measures Over General Instruments
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader & COA SME at TransPerfect Life Sciences, is joined by Katja Rudell, VP of Patient-Centered Outcomes at Kielo Research, to take a behind-the-scenes look at the reality of patient-centered instrument...
Process AI in Medical Device: What Works and What’s Next
The webinar will also explore the use of Process AI across life sciences operations. Instead of treating each process, such as post-market surveillance, complaint handling, systematic literature review and regulatory content authoring, like separate AI projects, this session will...
Integrating AI to Scale & Accelerate Workflows and Improve Pharma Product Launches
Bringing a new medical product to market has always been a challenge, though advances in recent tools have promised a new age of streamlined processes and accelerated time to launch. However, most pharma commercial AI pilots never make it past proof of concept due to siloed...
Optimizing COA/eCOA Workflows with Technology for Better Quality & Timelines
Efficient workflows are critical to keeping global COA/eCOA studies on schedule while ensuring the quality of localized content. This live webinar will explore how technology stacks and automation can streamline clinical localization from start to finish, through integrating...
Global by Design: Localizing UI/UX for Health Mobile Apps
In today’s global digital health landscape, localization goes far beyond translation. In health mobile applications, it means tailoring the user experience to cultural, linguistic, and even regulatory nuances across different regions. This discussion explores how localization in...
Optimizing Technology and Automation for Digital Health Products
Accurate and culturally appropriate translation of clinical outcome assessments (COAs), including patient-reported outcome measures, is essential to ensuring reliable data in multinational trials. Foundations of Clinical Outcome Assessment Localization will provide a practical...
Foundations of Clinical Outcome Assessment Localization
Accurate and culturally appropriate translation of clinical outcome assessments (COAs), including patient-reported outcome measures, is essential to ensuring reliable data in multinational trials. Foundations of Clinical Outcome Assessment Localization will provide a practical...
Life Sciences Learning Trends - Office Hours Q&A
Join the TransPerfect Learning team for an interactive virtual C3 Study Session, focused on the latest commercial learning trends transforming the life sciences industry. Whether you attended LTEN 2025 or are simply passionate about advancing learning & development in your...
AI in Pharmacovigilance: A Catalyst for Progress or a Tradeoff to Human Potential?
In an environment as high stakes as pharmacovigilance, AI is not just about technology implementation; it's about balancing compliance, patient safety, and developmental breakthroughs. In this session, industry experts Dr. Siva Kumar Buddha of Amgen alongside TransPerfect&...
LifeSci Talks COA Series | Meaningful Patient Involvement in HTA Decision-making: Where do we go from here?
In this episode of LifeSci Talks, Mark Wade, Global Practice Leader at TransPerfect Life Sciences, sits down with Alice Biggane, Outcomes Innovation and Research Lead at Pfizer, to discuss how PRO measures inform and impact endpoint adjudication and reimbursement decisions, due...
Patient Recruitment Strategies: Empowering Patients Through Accessible Information
From pre-screen to post-trial, patients require clear, personalized and supportive communication to navigate the clinical trial journey. Despite the industry’s recognition of patient centricity and the abundance of digital health solutions, many trial participants still struggle...
Digital Transformation Fireside Chat
In this fireside chat, Christine Buggle-Spearing and Dr. Gigi Shafai, Pharm.D., from TransPerfect Life Sciences, share practical strategies for modernizing medical affairs processes. The discussion covers how to design a digital-first strategy that creates value for both patients...
Integrating eCOAs and Digital Health Technologies for Patient-Centric Trials
The foundation of patient-first design is technology that connects seamlessly to support and meet patients where they are. In this session, leaders from Pfizer, THREAD, Datacubed, Obvio Health, and Merative will discuss how integrated digital ecosystems are breaking down platform...